• OPEN AN ACCOUNT
Indian Indices
Nifty
25,839.65 -120.90
(-0.47%)
Sensex
84,398.97 -267.31
( -0.32%)
Bank Nifty
59,222.35 -16.20
( -0.03%)
Nifty IT
38,130.60 -460.10
( -1.19%)
Global Indices
Nasdaq
47,580.49 -179.84
(-0.38%)
Dow Jones
6,861.32 -6.19
(-0.09%)
Hang Seng
50,565.27 -89.83
(-0.18%)
Nikkei 225
9,640.52 -4.57
(-0.05%)
Forex
USD-INR
90.09 0.19
(0.21%)
EUR-INR
104.90 0.24
(0.23%)
GBP-INR
120.04 0.25
(0.21%)
JPY-INR
0.58 0.00
(0.12%)

EQUITY - MARKET SCREENER

Laurus Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540222
INE947Q01028
91.1058881
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LAURUSLABS
80.75
55143.65
EPS(TTM)
Face Value()
Div & Yield %
12.65
2
0.12
 

quintegra solutions ltd
Bharat Dynamics gains on securing additional defence orders worth Rs 2,462 cr
Dec 02,2025
The major contracts include Anti-Tank Guided Missiles (ATGMs) and Surface-to-Air Missiles (SAMs) under emergency procurement. The ATGM orders are scheduled to be executed over 42 months, while the SAM orders will be completed within 12 months.

The company also clarified that neither its promoters nor the promoter group has any interest in the awarding authority, and the transaction does not qualify as a related-party deal under regulatory norms.

Bharat Dynamics is engaged in the manufacturing of missiles and allied defense equipment. The company provides the majority of its goods and services to the Indian Armed Forces and the Government of India.

The company’s standalone net profit jumped 76.2% to Rs 215.88 crore on an 114.2% surge in revenue from operations to Rs 1,147.08 crore in Q2 FY26 over Q2 FY24.